UCSF Rheumatology Board Review & Clinical Update – 2025

Overview

The UCSF Rheumatology Board Review & Clinical Update – 2025 is the 33rd Annual Rheumatology Board Review presented by UCSF. This hybrid continuing medical education (CME) course is designed for physicians preparing for the ABIM Rheumatology Subspecialty Exam as well as those seeking to update their clinical expertise in rheumatology through evidence-based practice and diagnostic guidance.

Format: Videos + PDFs
Date: August 21–23, 2025

• 26 Full-Length Masterclasses: Clear video recordings from the 2025 Live Session.
• 900+ Page Digital Syllabus: Every slide, reference, and treatment protocol in a searchable format.
• 120+ Diagnostic Images: A photographic review of rare and common rheumatologic manifestations.
• Lifetime Access Archive: No expiration. Your clinical library stays with you.

Agenda

This course delivers comprehensive content relevant to clinical practice and exam preparation in rheumatology. The agenda spans three days of presentations covering a wide range of rheumatologic conditions and therapeutic approaches.

• Welcome and Overview
  Drs. Mary Nakamura, Lianne Gensler, and Brett Dietz
• Systemic Lupus Erythematosus
  Dr. Maria Dall’Era
• RA Epidemiology, Extra-articular Manifestations & Complications
  Dr. Ted Mikuls
• Prevention and Treatment of Osteoporosis
  Dr. Mary Beth Humphrey
• Medication Safety and Prevention
  Dr. Gabby Schmajuk
• Osteoarthritis
  Dr. R. Krishna Chaganti
• Interpretation of Imaging Studies
  Dr. Thomas Link
• Antiphospholipid Syndrome
  Dr. Sarah Goglin
• Vasculitis
  Dr. Peter Merkel
• Systemic Sclerosis
  Dr. Francesco Boin
• Myositis and Myositis Mimics (Recorded)
  Dr. Andrew Mammen
• Rheumatoid Arthritis Therapy – 2025
  Dr. Jon Graf
• Pediatric Rheumatology
  Dr. Erica Lawson
• Quick Clinical Cases: A Photographic Review
  Dr. Les Miller
• Systemic Diseases with Rheumatic Manifestations
  Dr. Jonathan Graf
• Autoimmune Disease and the Lung
  Dr. Erin Wilfong
• Spondyloarthritis I
  Dr. Lianne Gensler
• Infectious Disease and Rheumatology
  Dr. Brett Dietz
• Pre-recorded lectures for post-conference viewing:
  • IgG4-Related Disease
    Dr. John Stone
  • Autoinflammatory Disease
    Dr. Daniel Kastner
  • Sports Medicine Parts I
    Dr. Carlin Senter
  • Sports Medicine Parts II
    Dr. Carlin Senter
  • Spondyloarthritis II
    Dr. Lianne Gensler
  • Mechanisms of Biologic Medications
    Dr. Judith Ashouri-Sinha
  • Crystalline Disease
    Dr. Tuhina Neogi

Learning Objectives

By the end of this course, participants will be able to:

1. Apply current, evidence-based standards of care to rheumatic diseases (including rheumatoid arthritis, systemic lupus erythematosus, scleroderma, other systemic, autoimmune diseases, autoinflammatory diseases, spondyloarthritis, osteoarthritis, osteoporosis, crystalline arthritis, and soft tissue musculoskeletal pain syndromes);
2. Improve diagnostic accuracy by application of best available recent data and expert guidance.
3. Refine, optimize, and monitor rheumatic disease treatments based on new knowledge of efficacy and safety.
4. Adopt newly approved treatments appropriately based on the latest medical evidence.
5. Refine approach to pain in rheumatic diseases.
6. Increase utilization of self-assessment.

Topics Covered (Sample from Previous Years)

Key clinical topics addressed in this course include:

• Systemic Lupus Erythematosus
• Myositis & Mimics
• Osteoporosis Prevention & Treatment
• Rheumatoid Arthritis Epidemiology & Complications
• Autoinflammatory Diseases
• Imaging Interpretation in Rheumatology

Speakers

• Mary Nakamura, MD
• Lianne Gensler, MD
• Brett Dietz, MD
• Maria Dall’Era, MD
• Ted Mikuls, MD
• Mary Beth Humphrey, MD
• Gabby Schmajuk, MD
• R. Krishna Chaganti, MD
• Thomas Link, MD
• Sarah Goglin, MD
• Peter Merkel, MD
• Francesco Boin, MD
• Andrew Mammen, MD
• Jon Graf, MD
• Erica Lawson, MD
• Les Miller, MD
• Erin Wilfong, MD
• John Stone, MD
• Daniel Kastner, MD
• Carlin Senter, MD
• Judith Ashouri-Sinha, MD
• Tuhina Neogi, MD

This course is sponsored by UCSF.

Target Audience

Trainees preparing for their initial board exam — as well as rheumatologists who are candidates for ABIM recertification — are the target audience. Diagnosing and managing complex and unusual clinical problems will be emphasized; an overview of significant advances related to clinical rheumatology will also be included.

Why This Topic Matters

The UCSF Rheumatology Board Review & Clinical Update – 2025 addresses key clinical challenges and evolving therapies in rheumatology, a specialty requiring up-to-date expertise to optimize patient outcomes. The course provides comprehensive, clinically relevant content that supports both board exam preparation and ongoing professional development.

MedHub Central offers this detailed rheumatology educational resource to strengthen diagnostic accuracy, treatment optimization, and clinical confidence, making it a valuable tool for rheumatology practitioners dedicated to evidence-based care.